Cargando…
Efficacy of Pentosan Polysulfate Treatment in Patients with Interstitial Cystitis/Bladder Pain Syndrome
OBJECTIVES: Pentosan Polysulfate (PPS) is the only oral treatment for interstitial cystitis (IC)-bladder pain syndrome (BPS) approved by the World Health Organization. Self-evaluation scales can provide more objective results on pre- and post-treatment satisfaction. The aim of this study was to inve...
Autores principales: | Arıkan, Mehmet Gürkan, Çakıroğlu, Basri |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bladder
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10627086/ https://www.ncbi.nlm.nih.gov/pubmed/37936582 http://dx.doi.org/10.14440/bladder.2023.866 |
Ejemplares similares
-
Pentosan polysulfate in patients with bladder pain
syndrome/interstitial cystitis with Hunner’s lesions or glomerulations:
systematic review and meta-analysis
por: Grigoryan, Bagrat, et al.
Publicado: (2022) -
Safety and efficacy of pentosan polysulfate in patients with bladder pain syndrome/interstitial cystitis: a multicenter, double–blind, placebo–controlled, randomized study
por: Kasyan, George, et al.
Publicado: (2021) -
The effect of Hydrodistension in combination with Pentosan Polysulfate on treatment outcomes and compliance in the treatment of bladder pain syndrome
por: Simsir, Adnan, et al.
Publicado: (2019) -
Maculopathy caused by pentosan polysulfate
por: Rosenberg, Daniel, et al.
Publicado: (2021) -
Pentosan Polysulfate: A Novel Therapy for the Mucopolysaccharidoses
por: Schuchman, Edward H., et al.
Publicado: (2013)